Cancer Therapy News and Research

RSS

Individualized neoantigen cancer therapy demonstrates safety and efficacy in early trials

For decades, researchers have worked to develop therapies that can prime the immune system to recognize and attack proteins on the surface of tumor cells.

8 Aug 2024

Review of fasting-mimicking diets in cancer treatment

Researchers present the role of cyclic fasting and fasting-mimicking diets (FMD) in cancer therapy.

8 Aug 2024

From discovery to approval: Vorasidenib approved by FDA for treatment of IDH-mutant gliomas

A new drug for treatment of a type of brain cancer, called IDH-mutant low-grade glioma, was approved Aug. 6 by the U.S. Food and Drug Administration (FDA).

7 Aug 2024

High initial drug doses may reduce cancer drug resistance

On July 28, 2024, Mikhail V. Blagosklonny M.D., Ph.D., from Roswell Park Comprehensive Cancer Center published a new editorial in Volume 16, Issue 14 of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science), entitled, "Targeted cancer therapy: the initial high concentration may slow down the selection for resistance."

6 Aug 2024

New target identified for melanoma resistant to current therapies

Some proteins, such as programmed cell death protein 1 (PD1), can stop the immune system from attacking cancer cells and, therefore, support the growth of cancer.

6 Aug 2024

Image-guided cancer treatment using biocompatible copper-based nanomaterials

Announcing a new article publication for BIO Integration journal. Cancer is a significant disease that poses a major threat to human health.

6 Aug 2024

Harnessing oncolytic viruses for cancer immunotherapy to improve treatment outcomes

Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, offering a unique potential to selectively target malignant cells while sparing normal tissues.

6 Aug 2024

Valproic acid shows promise in reducing COVID-19 severity and hospitalization

Researchers found that valproic acid (VPA), especially when combined with DHA, significantly reduces SARS-CoV-2 infection rates and severity, potentially activating antiviral mechanisms. Epidemiologic data support VPA's role in reducing COVID-19 severity and hospitalization rates.

6 Aug 2024

Breakthrough X-ray-sensitizers could revolutionize radiotherapy for cancer patients

Researchers at Xiamen University have made a significant advancement in cancer treatment by developing a novel class of X-ray-sensitizers (XSs) that could revolutionize radiotherapy.

31 Jul 2024

New dual kinase inhibitor MTX-531 shows promise in overcoming cancer therapy resistance

A team of researchers at the University of Michigan Health Rogel Cancer Center has designed a molecule that impairs signaling mediated by two key drivers of cancer therapy resistance.

29 Jul 2024

Advancing hepatic cell carcinoma treatment through mitochondrial DNA targeting

Hepatic cell carcinoma (HCC), the fifth most prevalent malignancy worldwide and the fourth leading cause of cancer-related mortality, poses significant therapeutic challenges.

29 Jul 2024

Fecal microbiota transplants can boost the effectiveness of immunotherapy in gastrointestinal cancers

Findings from a small, proof-of-concept clinical trial have suggested that fecal microbiota transplants (FMTs) can boost the effectiveness of immunotherapy in a range of gastrointestinal cancers.

25 Jul 2024

Physical modulation of the tumor microenvironment to enhance cancer therapy

Announcing a new article publication for BIO Integration journal. The tumor microenvironment (TME) has a crucial role in tumor development, metastasis, and recurrence.

19 Jul 2024

Deciphering the role of RET in cancer and breakthroughs in targeted treatments

Xueqing Hu , Ujjwol Khatri , Tao Shen , and Jie Wu, at University of Oklahoma Health Sciences Center, USA, provides a comprehensive review of the role of the RET (REarranged during Transfection) receptor tyrosine kinase in cancer development and the advancements in RET-targeted cancer therapies.

19 Jul 2024

Cancer Therapy News and Research

Individualized neoantigen cancer therapy demonstrates safety and efficacy in early trials

Review of fasting-mimicking diets in cancer treatment

From discovery to approval: Vorasidenib approved by FDA for treatment of IDH-mutant gliomas

High initial drug doses may reduce cancer drug resistance

New target identified for melanoma resistant to current therapies

Image-guided cancer treatment using biocompatible copper-based nanomaterials

Harnessing oncolytic viruses for cancer immunotherapy to improve treatment outcomes

Valproic acid shows promise in reducing COVID-19 severity and hospitalization

Breakthrough X-ray-sensitizers could revolutionize radiotherapy for cancer patients

New dual kinase inhibitor MTX-531 shows promise in overcoming cancer therapy resistance

Advancing hepatic cell carcinoma treatment through mitochondrial DNA targeting

Fecal microbiota transplants can boost the effectiveness of immunotherapy in gastrointestinal cancers

Physical modulation of the tumor microenvironment to enhance cancer therapy

Deciphering the role of RET in cancer and breakthroughs in targeted treatments

FDA approval of lifileucel: A milestone in tumor-infiltrating lymphocyte therapy for advanced melanoma

Breakthrough in aging research: Blocking IL-11 extends lifespan and improves health in mice

Scientists identify over 5,000 genetic variants that enable certain cancers to thrive

Targeted alpha therapy offers hope for glioblastoma patients

Fungal endophytes: A promising frontier for breast cancer treatment

Scientists identify over 5000 high-risk cancer gene variants

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News